TW217383B - - Google Patents

Info

Publication number
TW217383B
TW217383B TW078106510A TW78106510A TW217383B TW 217383 B TW217383 B TW 217383B TW 078106510 A TW078106510 A TW 078106510A TW 78106510 A TW78106510 A TW 78106510A TW 217383 B TW217383 B TW 217383B
Authority
TW
Taiwan
Prior art keywords
pct
formula
date mar
compounds
sec
Prior art date
Application number
TW078106510A
Other languages
English (en)
Chinese (zh)
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of TW217383B publication Critical patent/TW217383B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Error Detection And Correction (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Semiconductor Integrated Circuits (AREA)
  • Solid State Image Pick-Up Elements (AREA)
  • Amplifiers (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Artificial Filaments (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Television Systems (AREA)
  • Television Receiver Circuits (AREA)
  • Stereophonic System (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
TW078106510A 1988-09-12 1989-08-23 TW217383B (esLanguage)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24335088A 1988-09-12 1988-09-12

Publications (1)

Publication Number Publication Date
TW217383B true TW217383B (esLanguage) 1993-12-11

Family

ID=22918400

Family Applications (1)

Application Number Title Priority Date Filing Date
TW078106510A TW217383B (esLanguage) 1988-09-12 1989-08-23

Country Status (14)

Country Link
US (1) US5541339A (esLanguage)
JP (1) JP3380237B2 (esLanguage)
KR (1) KR0137959B1 (esLanguage)
AT (1) ATE198335T1 (esLanguage)
AU (1) AU632288B2 (esLanguage)
CA (1) CA1340215C (esLanguage)
DE (1) DE68929275T2 (esLanguage)
DK (1) DK175458B1 (esLanguage)
FI (1) FI103668B1 (esLanguage)
GR (1) GR3035589T3 (esLanguage)
LV (1) LV12806B (esLanguage)
NO (1) NO303498B1 (esLanguage)
TW (1) TW217383B (esLanguage)
WO (1) WO1990002746A1 (esLanguage)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2076465C (en) * 1992-03-25 2002-11-26 Ravi V. J. Chari Cell binding agent conjugates of analogues and derivatives of cc-1065
US5502068A (en) * 1995-01-31 1996-03-26 Synphar Laboratories, Inc. Cyclopropylpyrroloindole-oligopeptide anticancer agents
ATE446317T1 (de) 2001-05-11 2009-11-15 Ludwig Inst For Cancer Res Ltd Spezifische bindungsproteine und ihre verwendung
US20100056762A1 (en) 2001-05-11 2010-03-04 Old Lloyd J Specific binding proteins and uses thereof
NZ533310A (en) 2001-11-09 2004-12-24 Boehringer Ingelheim Pharma Benzimidazoles useful as protein kinase inhibitors
CA2494942A1 (en) * 2002-08-08 2004-02-19 Boehringer Ingelheim Pharmaceuticals, Inc. Substituted benzimidazole compounds
CA2501547A1 (en) * 2002-10-15 2004-04-29 Rigel Pharmaceuticals, Inc. Substituted indoles and their use as hcv inhibitors
AU2004255566B2 (en) * 2003-07-07 2010-07-08 Merk Patent Gmbh Malonamide derivatives
US20050209284A1 (en) * 2004-02-12 2005-09-22 Boehringer Ingelheim Pharmaceuticals, Inc. Tec kinase inhibitors
WO2007022258A1 (en) * 2005-08-17 2007-02-22 Schering Corporation Novel high affinity thiophene-based and furan-based kinase ligands
CN110613845B (zh) 2007-01-25 2025-08-26 达娜-法勃肿瘤研究所公司 抗egfr抗体在治疗egfr突变体介导的疾病中的用途
ES2542152T3 (es) 2007-03-15 2015-07-31 Ludwig Institute For Cancer Research Ltd. Método de tratamiento que emplea anticuerpos de EGFR e inhibidores de Src y formulaciones relacionadas
US9901567B2 (en) 2007-08-01 2018-02-27 Syntarga B.V. Substituted CC-1065 analogs and their conjugates
US9283276B2 (en) 2007-08-14 2016-03-15 Ludwig Institute For Cancer Research Ltd. Monoclonal antibody 175 targeting the EGF receptor and derivatives and uses thereof
HUE035798T2 (en) 2008-11-03 2018-05-28 Syntarga Bv CC-1065 analogues and conjugates
UA112291C2 (uk) 2010-04-21 2016-08-25 Синтарґа Б.В. Кон'югати аналогів cc-1065 і біфункціональні лінкери
US20150265641A1 (en) 2012-10-22 2015-09-24 Arnold Glazier Methods for the Effective Treatment of Metastatic Cancer
DE102013012622A1 (de) * 2013-07-30 2015-02-05 Clariant lnternational Ltd Neue sterisch gehinderte cyclische Amine
AU2015205574B2 (en) 2014-01-10 2019-08-15 Byondis B.V. Method for purifying Cys-linked antibody-drug conjugates
ES2722103T3 (es) * 2014-01-27 2019-08-07 Pfizer Agentes citotóxicos bifuncionales
CA2954934C (en) 2014-06-30 2023-09-26 Glykos Finland Oy Drug derivative and conjugates
DE102015000124A1 (de) * 2015-01-07 2016-07-07 Clariant International Ltd. Verfahren zur Stabilisierung von Polyamiden
KR102046862B1 (ko) * 2015-03-20 2019-11-20 화이자 인코포레이티드 Cti 약물작용발생단을 함유하는 이관능성 세포독성제

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4169888A (en) * 1977-10-17 1979-10-02 The Upjohn Company Composition of matter and process
US4301248A (en) * 1979-12-21 1981-11-17 Bristol-Myers Company Fermentation process for making rachelmycin
US4413132A (en) * 1980-11-18 1983-11-01 The Upjohn Company Antibiotic CC-1065 indoline intermediates
US4912227A (en) * 1984-02-21 1990-03-27 The Upjohn Company 1,2,8,8A-tetrahydrocyclopropa(c)pyrrolo(3,2-e)-indol-4-(5H)-ones and related compounds
CA1238907A (en) * 1984-02-21 1988-07-05 Robert C. Kelly 1,2,8,8a-tetrahydrocyclopropa¬c|pyrrolo(3,2-e)- indol-4(5h)-ones and related compounds
GB8528848D0 (en) * 1985-11-22 1985-12-24 Davy Mckee Poole Rolling mills
JP2598819B2 (ja) * 1986-12-19 1997-04-09 ジ・アップジョン・カンパニー 新規なｃｃ‐１０６５同族体

Also Published As

Publication number Publication date
DK41791D0 (da) 1991-03-08
WO1990002746A1 (en) 1990-03-22
FI103668B (fi) 1999-08-13
FI103668B1 (fi) 1999-08-13
US5541339A (en) 1996-07-30
NO910958D0 (no) 1991-03-11
AU632288B2 (en) 1992-12-24
NO910958L (no) 1991-05-10
KR0137959B1 (ko) 1998-05-15
KR900701801A (ko) 1990-12-04
ATE198335T1 (de) 2001-01-15
AU4192289A (en) 1990-04-02
JPH04500664A (ja) 1992-02-06
JP3380237B2 (ja) 2003-02-24
LV12806B (lv) 2002-05-20
CA1340215C (en) 1998-12-15
FI911193A0 (fi) 1991-03-11
LV12806A (en) 2002-03-20
DK175458B1 (da) 2004-11-01
DE68929275T2 (de) 2001-05-23
NO303498B1 (no) 1998-07-20
DE68929275D1 (de) 2001-02-01
GR3035589T3 (en) 2001-06-29
DK41791A (da) 1991-03-08

Similar Documents

Publication Publication Date Title
TW217383B (esLanguage)
TR200000197T2 (tr) Yeni bileşimler
ATE133181T1 (de) Dehydrodidemnin b
MX172669B (es) Combinaciones microbicidas sinergisticas, que contienen la 4,5-dicloro-2-octil-3-isotiazolona y ciertos biocidas comerciales
IL113462A0 (en) Substituted pyridylpyrazoles, their preparation and pesticidal compositions containing them
ZW24786A1 (en) Insecticidal pyrazolines
TR200000152T2 (tr) Yeni bileşikler.
PH24452A (en) (2,2-bis(aminomethyl 1,3,propanediol-n,n)platinum complexes
ATE63111T1 (de) Substituierte oximether, ihre verwendung als bioregulatoren zur senkung des endogenen ethylenspiegels in pflanzen.
ATE106205T1 (de) Pflegeset insbesondere für den reisebedarf.
ATE195055T1 (de) Insektizide zusammensetzung die diatomeenerde und siliziumdioxid enthalten
MX9302735A (es) 4'-metoxiacetofenonas halogenadas como microbicidas y preservativos.
MY107258A (en) 1-methoxypyrimidinyl-n-nitrophenyl-1h-1,2,4-triazole-3- sulphonamides, processes for their preparation and their use as herbicides.
NO960271D0 (no) Tiokarbamoylforbindelser anvendt som mikrobiocider
ATE87314T1 (de) Platin-arzneimittel.
NZ219093A (en) (gem-heterocyclodimethanamine-n,n') platinum complexes
ATE89555T1 (de) 3-substituierte 1-(2-halogen-alkoxybenzolsulfonyl)-3-heteroaryl-harnstoffe.
FR2574798B1 (fr) Nouvelle adenosine substituee en n6 et medicament la contenant comme principe actif
ATE73444T1 (de) Chemische zusammensetzungen und verwendung als brennstoff-additive.
MY110894A (en) New pyrazolylpryrazoles, processes for their preparation, as well as intermediates, and thier use as herbicides
SU1536770A1 (ru) Хлорид бензилгексаметилентетраммония, обладающий бактерицидной активностью в отношении сульфатвосстанавливающих бактерий и культур pseudomonas